Please assess the completion status of the following clinical trial:

Trial Title: Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Overweight or obese adults (age ≥45 yrs and BMI ≥25 kg/m2)~* prediabetes and OSA (AHI ≥ 5)~* regular life styles and schedules (no shift work in the past 6 months, no travel across time zones during the past 4 weeks)~* habitual bedtimes of at least 6 hours but not exceeding 9 hours will be eligible.~* not to take any medications during the study period with the exception of antihypertensives and lipid lowering agents~* not on hormone replacement therapy.~* have sedentary activities and no competitive athletes or subjects with high exercise levels.~Exclusion Criteria:~* previous or current treatment with supplemental oxygen~* requirement of supplemental oxygen or bi-level positive airway pressure for OSA treatment during titration~* presence of active infection, psychiatric disease or history of other significant illness (e.g., myocardial infarction, congestive heart failure, stroke, arrhythmia, chronic kidney or liver disease0~* clinical depression as evidenced by a score \>16 in CES-D scale~* smoking, or routine alcohol use (more than 2 drinks per day), or excessive caffeine intake (\>300mg per day)

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Continuous positive airway pressure (Type: ACTIVE_COMPARATOR): 2 weeks of continuous positive airway pressure (CPAP) treatment which includes wearing the CPAP mask for 8 hours each night
- Placebo (Type: PLACEBO_COMPARATOR): 2 weeks of oral administration of a placebo tablet 30min before bedtime

Based on this trial design, predict the completion outcome and termination type (if applicable).